Cargando…

Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease

Idiopathic Parkinson’s disease (PD) is a complex multifactorial disorder caused by the interplay of both genetic and non-genetic risk factors. Polygenic risk scores (PRSs) are one way to aggregate the effects of a large number of genetic variants upon the risk for a disease like PD in a single quant...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Sebastian, Laabs, Björn-Hergen, Kasten, Meike, Vollstedt, Eva-Juliane, Becktepe, Jos, Brüggemann, Norbert, Franke, Andre, Krämer, Ulrike M., Kuhlenbäumer, Gregor, Lieb, Wolfgang, Mollenhauer, Brit, Neis, Miriam, Trenkwalder, Claudia, Schäffer, Eva, Usnich, Tatiana, Wittig, Michael, Klein, Christine, König, Inke R., Lohmann, Katja, Krawczak, Michael, Caliebe, Amke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700849/
https://www.ncbi.nlm.nih.gov/pubmed/34946808
http://dx.doi.org/10.3390/genes12121859
_version_ 1784620857192087552
author Koch, Sebastian
Laabs, Björn-Hergen
Kasten, Meike
Vollstedt, Eva-Juliane
Becktepe, Jos
Brüggemann, Norbert
Franke, Andre
Krämer, Ulrike M.
Kuhlenbäumer, Gregor
Lieb, Wolfgang
Mollenhauer, Brit
Neis, Miriam
Trenkwalder, Claudia
Schäffer, Eva
Usnich, Tatiana
Wittig, Michael
Klein, Christine
König, Inke R.
Lohmann, Katja
Krawczak, Michael
Caliebe, Amke
author_facet Koch, Sebastian
Laabs, Björn-Hergen
Kasten, Meike
Vollstedt, Eva-Juliane
Becktepe, Jos
Brüggemann, Norbert
Franke, Andre
Krämer, Ulrike M.
Kuhlenbäumer, Gregor
Lieb, Wolfgang
Mollenhauer, Brit
Neis, Miriam
Trenkwalder, Claudia
Schäffer, Eva
Usnich, Tatiana
Wittig, Michael
Klein, Christine
König, Inke R.
Lohmann, Katja
Krawczak, Michael
Caliebe, Amke
author_sort Koch, Sebastian
collection PubMed
description Idiopathic Parkinson’s disease (PD) is a complex multifactorial disorder caused by the interplay of both genetic and non-genetic risk factors. Polygenic risk scores (PRSs) are one way to aggregate the effects of a large number of genetic variants upon the risk for a disease like PD in a single quantity. However, reassessment of the performance of a given PRS in independent data sets is a precondition for establishing the PRS as a valid tool to this end. We studied a previously proposed PRS for PD in a separate genetic data set, comprising 1914 PD cases and 4464 controls, and were able to replicate its ability to differentiate between cases and controls. We also assessed theoretically the prognostic value of the PD-PRS, i.e., its ability to predict the development of PD in later life for healthy individuals. As it turned out, the PD-PRS alone can be expected to perform poorly in this regard. Therefore, we conclude that the PD-PRS could serve as an important research tool, but that meaningful PRS-based prognosis of PD at an individual level is not feasible.
format Online
Article
Text
id pubmed-8700849
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87008492021-12-24 Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease Koch, Sebastian Laabs, Björn-Hergen Kasten, Meike Vollstedt, Eva-Juliane Becktepe, Jos Brüggemann, Norbert Franke, Andre Krämer, Ulrike M. Kuhlenbäumer, Gregor Lieb, Wolfgang Mollenhauer, Brit Neis, Miriam Trenkwalder, Claudia Schäffer, Eva Usnich, Tatiana Wittig, Michael Klein, Christine König, Inke R. Lohmann, Katja Krawczak, Michael Caliebe, Amke Genes (Basel) Article Idiopathic Parkinson’s disease (PD) is a complex multifactorial disorder caused by the interplay of both genetic and non-genetic risk factors. Polygenic risk scores (PRSs) are one way to aggregate the effects of a large number of genetic variants upon the risk for a disease like PD in a single quantity. However, reassessment of the performance of a given PRS in independent data sets is a precondition for establishing the PRS as a valid tool to this end. We studied a previously proposed PRS for PD in a separate genetic data set, comprising 1914 PD cases and 4464 controls, and were able to replicate its ability to differentiate between cases and controls. We also assessed theoretically the prognostic value of the PD-PRS, i.e., its ability to predict the development of PD in later life for healthy individuals. As it turned out, the PD-PRS alone can be expected to perform poorly in this regard. Therefore, we conclude that the PD-PRS could serve as an important research tool, but that meaningful PRS-based prognosis of PD at an individual level is not feasible. MDPI 2021-11-23 /pmc/articles/PMC8700849/ /pubmed/34946808 http://dx.doi.org/10.3390/genes12121859 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Koch, Sebastian
Laabs, Björn-Hergen
Kasten, Meike
Vollstedt, Eva-Juliane
Becktepe, Jos
Brüggemann, Norbert
Franke, Andre
Krämer, Ulrike M.
Kuhlenbäumer, Gregor
Lieb, Wolfgang
Mollenhauer, Brit
Neis, Miriam
Trenkwalder, Claudia
Schäffer, Eva
Usnich, Tatiana
Wittig, Michael
Klein, Christine
König, Inke R.
Lohmann, Katja
Krawczak, Michael
Caliebe, Amke
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
title Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
title_full Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
title_fullStr Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
title_full_unstemmed Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
title_short Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
title_sort validity and prognostic value of a polygenic risk score for parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700849/
https://www.ncbi.nlm.nih.gov/pubmed/34946808
http://dx.doi.org/10.3390/genes12121859
work_keys_str_mv AT kochsebastian validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT laabsbjornhergen validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT kastenmeike validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT vollstedtevajuliane validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT becktepejos validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT bruggemannnorbert validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT frankeandre validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT kramerulrikem validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT kuhlenbaumergregor validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT liebwolfgang validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT mollenhauerbrit validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT neismiriam validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT trenkwalderclaudia validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT schaffereva validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT usnichtatiana validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT wittigmichael validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT kleinchristine validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT koniginker validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT lohmannkatja validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT krawczakmichael validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease
AT caliebeamke validityandprognosticvalueofapolygenicriskscoreforparkinsonsdisease